Everhope Oncology, a groundbreaking joint venture between Narayana Health, W Health Ventures, and 2070 Health, has recently secured $10 million in seed funding. This substantial investment marks a significant step towards establishing state-of-the-art medical and surgical cancer care facilities in Delhi and Mumbai, with ambitious plans to expand to ten cities within the next three years. Their mission? To deliver comprehensive cancer treatment and support services in comfortable, patient-centric environments, outside the traditional, often overwhelming, hospital settings.
Addressing India’s Growing Cancer Burden: A Critical Need
India faces a rapidly escalating cancer crisis. With over 8 million individuals currently battling the disease, and projections indicating that one in nine Indians will develop cancer in their lifetime, the need for enhanced cancer care infrastructure is undeniable. This surge in cases necessitates a substantial increase in medical resources, with estimates suggesting a requirement for an additional 40,000 chemotherapy and surgical beds in the coming years. However, the nation grapples with a severe shortage of oncologists, with a stark disparity of one oncologist for every 2,000 cancer patients, compared to the much more favorable ratio in developed nations. This shortage leads to overburdened healthcare professionals and unacceptably long patient wait times.
Furthermore, the persistent stigma surrounding cancer significantly hinders early detection and treatment. Fear of painful procedures and overcrowded hospital environments discourages many from seeking timely screenings, often leading to diagnoses at advanced stages, which substantially increases mortality rates.
New Facilities: Prioritizing Patient Experience and Comfort
Everhope Oncology’s planned centers are designed to directly address these challenges. By creating a serene, infection-controlled environment, the venture aims to minimize wait times and prioritize patient comfort. These facilities will offer a comprehensive range of services, including chemotherapy, radiation, surgery, and palliative care. A crucial aspect of Everhope’s approach is the implementation of globally validated protocols, overseen by a clinical board of experienced oncologists in collaboration with Narayana Health, ensuring high-quality outcomes.
Beyond medical treatments, Everhope will provide a 24/7 concierge service to assist patients throughout their treatment journey. This service will be complemented by mental health counseling, nutritional consultations, and pain management, all aimed at reducing anxiety, promoting timely screenings, and transforming perceptions of cancer care.
Leadership Vision: Transforming Cancer Care Perceptions
Viren Shetty, vice chairman of Narayana Health, articulated the vision behind Everhope, emphasizing the need to move away from the traditional, often distressing, imagery associated with cancer treatment. He highlighted the global trend of dedicated cancer centers that prioritize patient comfort and support, and expressed Everhope’s commitment to bringing this experience closer to patients’ homes. Pankaj Jethwani, managing partner at W Health Ventures, underscored the rapid advancements in cancer care worldwide, including daycare chemotherapy centers, advanced diagnostics, and innovative therapies like CAR-T therapy. He emphasized Everhope’s goal to drive oncology innovation in India by empowering entrepreneurial oncologists to become business owners.
This seed funding represents a pivotal moment in India’s fight against cancer. Everhope Oncology’s commitment to patient-centric care, combined with innovative treatment approaches and a focus on addressing the unique challenges faced by Indian patients, promises to transform the landscape of cancer care in the years to come.
Subscribe:
